Skip to main content
Clinical Trials/NCT03558763
NCT03558763
Completed
Not Applicable

Remote MONITORing of Patients With Chronic Obstructive Pulmonary Disease Using a Tablet System. A Randomized Cross Over Pilot Study of Feasibility Evaluation and Quality of Life Measurements

Vastra Gotaland Region1 site in 1 country70 target enrollmentJune 7, 2018
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Vastra Gotaland Region
Enrollment
70
Locations
1
Primary Endpoint
Change of SF-12 over each treatment period
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This clinical investigation will evaluate the patient-equipment interface and patient preference in the use of modern possibilities for remote monitoring of patients with COPD in a personalized care approach.

Detailed Description

The primary objective is to evaluate the impact and feasibility of tele monitoring and video contact in personalized care of moderate and severe COPD patients. This should be compared to normal standards of care. The cross-over design evaluates the influence on general HRQOL of this tablet and monitoring system.

Registry
clinicaltrials.gov
Start Date
June 7, 2018
End Date
June 15, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Vastra Gotaland Region
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Willingness to participate and provision of informed consent
  • Diagnosis of COPD
  • FEV1/FVC (post bronchodilator) \<0.7
  • GOLD severity grade D
  • FEV, \< 80% predicted
  • Cognitive ability relevant for the studies as judged by the investigator
  • Living in their own home and able to manage their activities of daily living

Exclusion Criteria

  • Rapidly progressing severe disease other than COPD and COPD-related diseases, influencing the Health-Related Quality of Life (HRQOL) during the study time as judged by the investigator
  • Long-term stay ( \>2 weeks) away from home during the study period, where there are no possibility to get internet connection
  • COPD exacerbation during 1 month before start of study

Outcomes

Primary Outcomes

Change of SF-12 over each treatment period

Time Frame: 13 month study, measure points at day 0 (1), week 26 (2), week 30 (3) and week 56 (4)

The primary objective is to evaluate the impact and feasibility of tele monitoring and video contact in personalized care of moderate and severe COPD patients. This should be compared to normal standards of care. The cross-over design evaluates the influence on general HRQOL of this tablet and monitoring system.

Study Sites (1)

Loading locations...

Similar Trials